NO20003825D0 - 1,3,4 - oxadiazolonderivater - Google Patents

1,3,4 - oxadiazolonderivater

Info

Publication number
NO20003825D0
NO20003825D0 NO20003825A NO20003825A NO20003825D0 NO 20003825 D0 NO20003825 D0 NO 20003825D0 NO 20003825 A NO20003825 A NO 20003825A NO 20003825 A NO20003825 A NO 20003825A NO 20003825 D0 NO20003825 D0 NO 20003825D0
Authority
NO
Norway
Prior art keywords
oxadiazolone derivatives
oxadiazolone
derivatives
Prior art date
Application number
NO20003825A
Other languages
English (en)
Other versions
NO20003825L (no
NO317102B1 (no
Inventor
Piyasena Hewawasam
Min Ding
Jr John E Starret
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20003825L publication Critical patent/NO20003825L/no
Publication of NO20003825D0 publication Critical patent/NO20003825D0/no
Publication of NO317102B1 publication Critical patent/NO317102B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20003825A 1998-01-29 2000-07-26 1,3,4 - oxadiazolonderivater NO317102B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29
PCT/US1999/000910 WO1999038510A1 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone

Publications (3)

Publication Number Publication Date
NO20003825L NO20003825L (no) 2000-07-26
NO20003825D0 true NO20003825D0 (no) 2000-07-26
NO317102B1 NO317102B1 (no) 2004-08-09

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003825A NO317102B1 (no) 1998-01-29 2000-07-26 1,3,4 - oxadiazolonderivater

Country Status (27)

Country Link
US (1) US6034113A (no)
EP (1) EP1051173A4 (no)
JP (1) JP2002527352A (no)
KR (1) KR20010077838A (no)
CN (1) CN1150175C (no)
AR (1) AR010712A1 (no)
AU (1) AU735704B2 (no)
BG (1) BG104706A (no)
BR (1) BR9913010A (no)
CA (1) CA2318830A1 (no)
CO (1) CO5090837A1 (no)
EE (1) EE04089B1 (no)
GE (1) GEP20032914B (no)
HU (1) HUP0102025A3 (no)
ID (1) ID26909A (no)
IL (1) IL137518A0 (no)
LT (1) LT4838B (no)
LV (1) LV12559B (no)
NO (1) NO317102B1 (no)
NZ (1) NZ505409A (no)
PL (1) PL342060A1 (no)
RU (1) RU2202548C2 (no)
SK (1) SK10852000A3 (no)
TR (1) TR200002019T2 (no)
TW (1) TW550075B (no)
UA (1) UA58579C2 (no)
WO (1) WO1999038510A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6162817A (en) * 1999-01-29 2000-12-19 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
MXPA03007397A (es) 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
CZ20032829A3 (cs) * 2001-04-16 2005-03-16 Tanabe Seiyaku Co., Ltd. Heterocyklické sloučeniny
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
HK1207562A1 (en) 2012-01-18 2016-02-05 苏州泰飞尔医药有限公司 High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
AU2018225758A1 (en) * 2017-02-24 2019-09-05 Ovid Therapeutics Inc. Methods of treating seizure disorders
WO2020086149A1 (en) 2018-10-26 2020-04-30 University Of South Florida Drug for treating tinnitus
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (no) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone

Also Published As

Publication number Publication date
NZ505409A (en) 2003-08-29
EP1051173A1 (en) 2000-11-15
TW550075B (en) 2003-09-01
KR20010077838A (ko) 2001-08-20
SK10852000A3 (sk) 2002-02-05
LV12559B (en) 2001-04-20
CO5090837A1 (es) 2001-10-30
EE04089B1 (et) 2003-08-15
LT2000068A (en) 2001-03-26
UA58579C2 (uk) 2003-08-15
PL342060A1 (en) 2001-05-21
CN1150175C (zh) 2004-05-19
IL137518A0 (en) 2001-07-24
NO20003825L (no) 2000-07-26
GEP20032914B (en) 2003-03-25
US6034113A (en) 2000-03-07
WO1999038510A1 (en) 1999-08-05
AU735704B2 (en) 2001-07-12
NO317102B1 (no) 2004-08-09
AR010712A1 (es) 2000-07-12
RU2202548C2 (ru) 2003-04-20
ID26909A (id) 2001-02-15
HUP0102025A2 (hu) 2001-11-28
EE200000447A (et) 2001-12-17
TR200002019T2 (tr) 2000-11-21
CA2318830A1 (en) 1999-08-05
EP1051173A4 (en) 2002-07-31
BR9913010A (pt) 2001-05-08
LV12559A (en) 2000-11-20
HUP0102025A3 (en) 2002-01-28
LT4838B (lt) 2001-08-27
AU2230899A (en) 1999-08-16
BG104706A (en) 2001-04-30
JP2002527352A (ja) 2002-08-27
CN1289249A (zh) 2001-03-28

Similar Documents

Publication Publication Date Title
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO20010193L (no) Tiobenzimidazol-derivater
ATE236136T1 (de) Benzosulfonderivate
NO20010514L (no) Aminometylkarboksylsyre-derivater
ATE259810T1 (de) Phenyl-xanthinderivate
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE69917327D1 (de) 3,3-biarylpiperidin- und 3,3-biarylmorpholinderivate
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DK1149106T3 (da) 4,5-azolo-oxindoler
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de) Chromanderivate
DK1060183T3 (da) 5-deoxycytidinderivater
ID26368A (id) Turunan-turunan 2 deoksi higromisin
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate
FI980476A0 (fi) Foervaermare foer dieselbraensle

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees